Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Kennewick
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kennewick, WA

Studies commonly pay $75 to $4,500 per completed study

55 clinical trials are currently recruiting participants within 30 miles of Kennewick. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

55studies recruiting
4+research centers nearby
2condition categories
Live from the NIH registry

Studies recruiting near Kennewick right now

Top 25 of 55 recruiting studies, sorted by proximity — each links to its official registry page

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma Phase 3 Interventional 264 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT06475989)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05929768)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Malignant Solid Neoplasm N/A Interventional 760 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT06295367)

Family Communications After Genetic Testing

Colon Adenocarcinoma, Colorectal Adenocarcinoma N/A Interventional 4,186 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07143487)

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma Phase 2 Interventional 152 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04858334)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Anaplastic Large Cell Lymphoma, ALK-Negative, Follicular Helper T-Cell Lymphoma Phase 3 Interventional 294 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Eastern Cooperative Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT06724237)

Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

Genetic Disease N/A Observational 20,000 participants sought
Pacific Northwest National Laboratory — Richland, Washington (8.1 mi) · Sponsor: National Human Genome Research Institute (NHGRI)
See eligibility & contact on ClinicalTrials.gov (NCT02450851)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Hodgkin Lymphoma, Non-Hodgkin Lymphoma N/A Observational 2,000 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT06002828)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05812807)

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Phase 2 Interventional 112 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04511013)

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma Phase 2 Interventional 46 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT03191149)

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03418961)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04239573)

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
Kadlec Clinic Hematology and Oncology — Kennewick, Washington (2.0 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222800)
Actively enrolling

Studies you may be able to join near Kennewick

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Kennewick

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Kadlec Clinic - Hematology and Oncology

★ 4.3
7360 W Deschutes Ave, Kennewick, WA 99336
(509) 942-2540
"My Dr is from Pakistan she is very brilliant and positive with patients very nice she is the future of this hospital we are really happy with her."
— Ron Patel, 5★

Tri-Cities Research District

3250 Port of Benton Blvd, Richland, WA 99354
(509) 375-0360

Kadlec Clinic - Rheumatology

★ 3.5
6710 W Okanogan Pl, Kennewick, WA 99336
(509) 942-2528
"I've only been here once after being on a 9 month waiting list.. I've seeing several Rheumatologest without finding one who could help me over ten ye…"
— D E W Adventures, 4★

Kadlec Neuroscience Center

★ 2.8
1100 Goethals Dr, Richland, WA 99352
"Dr. Spencer is different. He is a refreshing reminder that not all providers should be cold and clinical. He maintained being professional and was ve…"
— Vlad III, 5★

Clinical trials in Kennewick: what's recruiting

The Kennewick area currently has 55 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kennewick, the most active research areas are:

  • Cancer & Oncology18 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Kennewick, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kennewick

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kennewick participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Kennewick?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Kennewick?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Kennewick?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Kennewick.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kennewick typically complete one or two studies per year.

Paid clinical trials near Kennewick

Other metros within reach

Spokane, WA291 Bellevue, WA1,510 Tacoma, WA1,454 Seattle, WA1,503 Vancouver, WA1,031 Marysville, WA200 Portland, OR1,031 Nampa, ID261

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Kennewick Bladder Issues Due To Spinal Cord Injury in Kennewick All conditions

More of WA

Bellevue1,510 Seattle1,503 Bremerton1,475 Tacoma1,454 Vancouver1,031 Spokane291 Olympia229 Marysville200

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts